Targeting Inflammation Slows STK11 Mutation-Driven Polyp Growth
Aug 14, 2018
A study shows that LKB1 deficiency in T cells increases gastrointestinal polyposis development.
Recent Content
Using Targeted Deep Sequencing to Detect ctDNA in Pancreatic Cancer
Aug 14, 2018
Study shows that ctDNA levels measured by targeted deep sequencing sensitively indicate the presence of cancer.
Hurdles Remain for Lung Cancer Screening Programs
Aug 13, 2018
Low-dose CT screening for lung cancer is recommended for certain individuals, but two new studies highlight some of the limitations and growing pains of a screening program.
Researchers Call for More Conservative Treatment of Small Thyroid Cancers
Aug 13, 2018
The steep increase in thyroid cancer diagnosis has not been mirrored by increasing mortality rates and is likely due to widespread overdiagnosis of small neoplasms.
Bortezomib-Based Therapy Effective for Relapsed/Refractory Myeloma
Aug 13, 2018
Relapsed or refractory multiple myeloma patients experience high response rates, overall survival with bortezomib-based therapy.
Could HER2 Amplification Aid in the Prognosis of HER2-Positive Breast Cancer?
Aug 13, 2018
The presence of HER3 expression and a high HER2/CEP17 ratio distinguish a group of invasive HER2-positive ductal breast cancer patients who have a worse prognosis.
Mediastinal Mass in a Young Woman With Chest Pain, Cough, Malaise
Aug 10, 2018
A 27-year-old woman presents with chest pain, cough, and general malaise. Imaging reveals an anterior mediastinal mass. What is your diagnosis?
Patients With DLBCL, FL Face Increasing Economic Burden
Aug 10, 2018
DLBCL and FL patients experience considerable economic burden during the first year after diagnosis.
Immunotherapy Rechallenge Successful in Some Cancer Patients
Aug 10, 2018
Patients treated with anti–PD-1 or anti–PD-L1 inhibitors in clinical trials were successfully retreated with the inhibitors after discontinuing the treatment.
Obinutuzumab/Lenalidomide Combo Safe, Effective in Advanced Follicular Lymphoma
Aug 9, 2018
The combination of obinutuzumab and lenalidomide was found to be effective in relapsed or refractory follicular B-cell lymphoma.
